Clinical Trials Directory

Trials / Completed

CompletedNCT04582110

The Role of OCTA in Patients Affected by Beta Thalassemia

Retinal and Choriocapillaris Vascular Features in Patients With Beta Thalassemia by Means of Optical Coherence Tomography Angiography

Status
Completed
Phase
Study type
Observational
Enrollment
82 (actual)
Sponsor
Federico II University · Academic / Other
Sex
All
Age
35 Years – 50 Years
Healthy volunteers
Accepted

Summary

To investigate, using optical coherence tomography angiography (OCTA), the retinal and choriocapillaris vascular features in patients affected by Beta Thalassemia. Moreover we analyzed the structural retinal parameters (ganglion cell complex and retinal nerve fiber layer), using optical coherence tomography (OCT) in these patients

Detailed description

Beta Thalassemia is one of the most common genetic hemoglobinopathy characterized by a defective β globulin chain synthesis leading to hemolysis and ineffective erythropoiesis. The study investigated the changes in retinal and choriocapillaris vascular features using optical coherence tomography angiography, a novel and noninvasive diagnostic technique that allows a detailed analysis of retinal and choriocapillaris blood flow.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTOptical coherence tomography angiographyEach subject underwent Optical coherence tomography angiography (a non-invasive, fast, diagnostic imaging technique)

Timeline

Start date
2019-10-01
Primary completion
2020-02-25
Completion
2020-02-28
First posted
2020-10-09
Last updated
2021-02-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04582110. Inclusion in this directory is not an endorsement.